Aggregation-induced emission luminogens (AIEgens) have garnered significant attention in nanomedicine owing to their unique photophysical properties, particularly enhanced fluorescence quantum yields and superior photostability in aggregated states. This review summarizes recent progress in leveraging nanoprecipitation techniques for the fabrication of AIE nanoparticles, with emphasis on their translational applications in targeted drug delivery and advanced bioimaging platforms. By elucidating fundamental mechanistic principles governing AIE phenomena alongside methodological innovations in nanoparticle synthesis, we systematically classify diverse AIE molecular architectures tailored for specific biomedical contexts. The analysis underscores how AIE nanoparticles overcome intrinsic limitations of conventional systems through amplified imaging precision and therapeutic efficacy. Scalable manufacturing and long-term biocompatibilities as persistent challenges are delineated to propose prioritized research trajectories. Finally, emerging clinical trends are discussed to advance the practical implementation of AIE nanoparticle technology in integrated theranostic paradigms.


扫码关注我们
求助内容:
应助结果提醒方式:

